34 matches for your search in the start-up spotlight

rss
matching the following criteria

image description
SARS-CoV-2: Cell phone and genome data allow targeted tracing of infection pathways

Scientists from the Jena start-up nanozoo GmbH and Jena University Hospital present analysis

28-Jan-2025

To track the spread of pathogens such as SARS-CoV-2 in a more targeted manner, anonymized mobile phone data and other metadata (such as zip codes) can be combined with genome data. A systematic evaluation of such combined data pools has now been presented by scientists from the Jena-based ...

more

image description
New study on the benefits of Covid-19 nasal spray vaccination

Another milestone reached: researchers work together with Swiss biotech start-up to further develop the vaccine

29-Feb-2024

Rocketvax AG, together with the German Research Foundation (DFG), has financially supported a study carried out as part of a joint project of the Swiss National Science Foundation (SNSF, National Research Program “Covid-19,” NRP 78) and the German Research Foundation (DFG) “Recoding the ...

more

image description
Innovative corona vaccine developed

New vaccine technology could protect from future Coronaviruses and variants

05-Oct-2023

Studies of a ‘future-proof’ vaccine antigen candidate have shown that just one antigen can be modified to provide a broadly protective immune response in animals, suggesting that a single vaccine with combinations of these novel antigens could protect against an even greater range of current and ...

more

image description
New vaccine concept against SARS-CoV-2 successfully tested

University of Basel and biotech start-up RocketVax present a vaccine concept that could lead to a new generation of vaccines

25-May-2023

Researchers at the University of Basel have developed a new approach for a vaccine against COVID-19. This vaccine is based on a modified coronavirus that can enter body cells and trigger an effective immune response but cannot multiply in the body. In animal studies, the vaccine effectively ...

more

image description
Wyss Institute at Harvard University launches SPEAR Bio

Spear Bio is working towards commercializing its first assay, which accurately assesses levels of SARS-CoV-2-neutralizing antibodies in dried-blood spot samples

13-Sep-2022

The Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc. announced that the Institute’s DNA nanotechnology-driven ultrasensitive SPEAR protein-detection technology has been licensed to the newly formed Boston-based startup. Spear Bio has signed a ...

more

image description
Technology transfer award for PCR rapid test device for infection diagnostics

In-vitro-Diagnostic company Spindiag, a University of Freiburg and Hahn-Schickard spin-off, has been recognized for its research-based development

19-Apr-2022

Spindiag GmbH, together with the University of Freiburg and the Hahn-Schickard-Gesellschaft für angewandte Forschung e.V., was awarded the Technology Transfer Prize 2020 from the German Physical Society (DPG) on April 09, 2022 for the development of the PCR-based rapid test system Rhonda. The ...

more

image description
Customized coating designs against resistant bacteria and viruses, including SARS-CoV-2

Spartha Medical receives €2.4M in financing from European Innovation Council

01-Feb-2022

Spartha Medical, a French medtech start-up specialized in developing multifunctional antimicrobial, antiviral and anti-inflammatory coatings, announces it has received €2.4M ($2.75M) in grants and an additional undisclosed equity financing from the European Innovation Council (EIC) Fund. Spartha ...

more

image description
A spray to protect against lung damage from Covid-19

Startup develop an RNA-based drug

18-Jan-2022

rnatics, a startup at the Technical University of Munich (TUM), has created an RNA-based drug to prevent lung damage from infections as seen in serious Covid-19 cases. The Federal Ministry of Education and Research (BMBF) is providing 7 million euros in funding to support the development of the ...

more

image description
Pantherna Therapeutics secures EUR 4.0 Mio. follow-on financing to advance its therapeutic mRNA development programs  

13-Jan-2022

Pantherna Therapeutics announces the successful completion of a follow-on financing round totaling EUR 4.0 Mio. led by existing investors Riesner Verwaltungs GmbH and High-Tech Gründerfonds. The proceeds of this round will be used to accelerate preclinical development activities for its lead ...

more

image description
COVID-19 Oral Vaccine and Antibody Booster

Biotechnology Breakthrough by start-up DreamTec

06-Jan-2022

Vaccines have been a trending topic ever since the coronavirus outbreak two years ago. DreamTec Research Limited has its major breakthrough in developing a COVID-19 oral vaccine. In its recently published peer-reviewed paper in an international medical journal Vaccines,which demonstrates ...

more

Page 1 From 4
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE